|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/52 | |
| A61K 31/7076 | |||
| A61P 27/02 |
| (11) | Patento numeris | 1778239 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05762145.0 |
| Europos patento paraiškos padavimo data | 2005-07-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-05-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-08-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IL2005/000762 |
| Data | 2005-07-18 |
| (87) | Numeris | WO 2006/011130 |
| Data | 2006-02-02 |
| (30) | Numeris | Data | Šalis |
| 591628 P | 2004-07-28 | US |
| (72) |
FISHMAN, Pnina, IL
LORBER, Ilana, IL
COHN, Ilan, IL
REITBLAT, Tatiana, IL
|
| (73) |
Can-Fite Biopharma Ltd.,
10 Bareket Street, 49170 Petach Tikva,
IL
|
| (54) | ADENOSINE A3 RECEPTOR AGONISTS FOR THE TREATMENT OF DRY EYE DISORDERS INCLUDING SJOGREN`S SYNDROME |
| ADENOSINE A3 RECEPTOR AGONISTS FOR THE TREATMENT OF DRY EYE DISORDERS INCLUDING SJOGREN`S SYNDROME |